NasdaqCM - Nasdaq Real Time Price USD

BioXcel Therapeutics, Inc. (BTAI)

Compare
0.3400
-0.0398
(-10.48%)
At close: January 24 at 4:00:01 PM EST
0.3170
-0.02
(-6.76%)
Pre-Market: 7:03:38 AM EST

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
BIOXCEL CORPORATION Beneficial Owner of more than 10% of a Class of Security Sale Jun 25, 2021 8,546,750
BIOXCEL HOLDINGS, INC Beneficial Owner of more than 10% of a Class of Security Sale Jun 25, 2021 --
MACK DAVID J Director Conversion of Exercise of derivative security Dec 31, 2024 54,178
MEHTA VIMAL Chief Executive Officer Sale Dec 16, 2024 7,747,110
NANDABALAN KRISHNAN Director and Beneficial Owner of more than 10% of a Class of Security Sale Apr 6, 2023 8,546,750
O'NEILL VINCENT J. M.D. Officer Sale Dec 16, 2024 19,957
RODRIGUEZ JAVIER Officer Sale Dec 16, 2024 24,423
STEINHART RICHARD I Chief Financial Officer Sale Dec 16, 2024 20,932
WILEY MATTHEW T Officer Sale Oct 3, 2024 19,011
YOCCA FRANK D. PH.D. Officer Sale Dec 16, 2024 28,931

Related Tickers